Aromatase Inhibitors and Arthralgias: A New Frontier in Symptom Management for Breast Cancer Survivors
- 1 September 2007
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (25) , 3797-3799
- https://doi.org/10.1200/jco.2007.11.9529
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast CancerJournal of Clinical Oncology, 2007
- Aromatase inhibitor-associated arthralgia syndromeThe Breast, 2007
- Aromatase Inhibitors and Bone Health in Women With Breast CancerJournal of Clinical Oncology, 2006
- Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast CancerJournal of Clinical Oncology, 2006
- Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal WomenJournal of Clinical Oncology, 2005
- Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivationArthritis & Rheumatism, 2005
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004Journal of Clinical Oncology, 2005
- American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast CancerJournal of Clinical Oncology, 2003
- Nodal Metastasis Is Highly Consistent in Squamous Cell Carcinoma of the VulvaJournal of Clinical Oncology, 2001
- Postchemotherapy rheumatism.Journal of Clinical Oncology, 1993